Security key
58471K202
Medicus Pharma Ltd. - Common Shares, no par value per share (MDCX)
CUSIP: 58471K202
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Shares, no par value per share
- Total 13F shares
- 1,602,371
- Total 13F value
- $725,294
- Share change
- -85,000
- SEC-reported price per share
- $0.45
- Number of holders
- 2
- Value change
- -$38,508
- Number of sells
- 2
- Shares outstanding
- 54,898,649
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
2
Top holders
2
MDCX full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Medicus Pharma Ltd. SEC filings
Medicus Pharma Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 58471K202
Recent filing periods:
Ownership snapshot
Top reported holders of MDCX - Medicus Pharma Ltd. - Common Shares, no par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Kenneth R. Melani
Disclosed value leader
Kenneth R. Melani
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G
3/4/5
13F
Lead comparable stake: 18%
13D/G row: Kenneth R. Melani
Showing 1-6 of 15 holder rows.
Quick read
Kenneth R. Melani leads the comparable SEC ownership view at 18%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Kenneth R. Melani's linked filing trail.
Comparable ownership
Top 5
Kenneth R. Melani
18%
ARMISTICE CAPITAL, LLC
5%
Raza Bokhari
4.8%
John Jason Hathaway
4.5%
Ajay Raju
3.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Kenneth R. Melani |
13D/G
3/4/5
Melani Kenneth R. · 10%+ Owner
|
18%
|
$9,843,685
3,248,741 shares
|
-$227,250 | 30 Jun 2025 |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
5%
|
$2,835,244
935,724 shares
|
-$1,000,736 | 30 Jun 2025 |
| Raza Bokhari |
13D/G
3/4/5
Bokhari Raza · Chief Executive Officer, Director
|
4.8%
|
$2,375,437
1,218,173 shares
|
+$316,875 | 31 Dec 2025 |
| John Jason Hathaway |
13D/G
John Hathaway
|
4.5%
|
$2,426,885
800,952 shares
|
$0 | 30 Jun 2025 |
| Ajay Raju |
13D/G
3/4/5
Raju Ajay · Director
|
3.7%
|
$893,750
2,031,250 shares
|
+$13,750 | 31 Mar 2026 |
| James P. Quinlan |
3/4/5
Chief Financial Officer
|
0.5%
|
$903,404
274,147 shares
mixed-class rows
|
— | 13 Aug 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
2
Shares
1,602,371
Rows available
2
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
20
Q2 2026 holders
2
Holder diff
-18
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend